USPTO serial 79340665
LANDSCAPE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 25, 2024
- Examiner
- SINGH, DEEP K
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with LANDSCAPE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christina M. Licursi
Christina M. Licursi Wolf, Greenfield & Sacks, P.C.600 Atlantic AvenueBoston, MA 02210UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic preparations and reagents for scientific or research use; Chemical reagents for non-medical purposes; diagnostic reagents for in vitro use in biochemistry, clinical chemistry, science and medical research; buffer solutions and reagents for use with laboratory apparatus, namely, buffer solutions and reagents for scientific and research use for use with separation apparatus and analysis apparatus; diagnostic biomarkers, namely, nucleic acids, proteins and other biochemical ligands all of the foregoing being diagnostic preparations for scientific or research use; diagnostic kits comprised of diagnostic reagents and assay components for scientific and clinical research | ACTIVE | — |
| 005 | Diagnostic medical reagents and assay components for testing of body fluids, including blood and plasma, and cells; diagnostic kits comprised of diagnostic reagents and assay components for clinical and medical use; all the foregoing not including any such goods that are prescription only pharmaceuticals, but including such non-pharmaceutical goods that are for companion diagnostics | ACTIVE | — |
| 009 | Apparatus, equipment and instruments for cytology, histology and for use in detecting cancerous conditions not for medical use, but all for laboratory use, diagnostic or general research use in the fields of cytology and histology, namely, specimen collection and handling vials, pipettes, burettes, dispensing bottles for laboratory reagents, microplates and assay plates in the nature of test tubes, sample test tubes; Apparatus, equipment and instruments for cytology, histology and for use in detecting cancerous conditions not for medical use, but all for laboratory use, diagnostic or general research use in the fields of cytology and histology, namely, DNA analysis apparatus for laboratory use, apparatus for analysing genes for laboratory use; laboratory apparatus in the nature of cassettes for harvesting rare cells for use in laboratory, diagnostic or general research use; cell analyzer in the nature of flow cytometers and flow-based analyzers providing quantitative cell analysis for scientific, laboratory or general research use and disposable cassettes therefor; apparatus for use in testing and analysing blood not for medical use, and all for laboratory use, diagnostic or general research use, namely, sample test tubes, vials, disposable dispenser syringes, pipettes, dispensing bottles for laboratory reagents, microplates and assay plates in the nature of test tubes; parts and fittings for the aforesaid goods, namely medical laboratory research instruments for use in the detection of cancer | ACTIVE | — |
| 010 | Medical apparatus, equipment and instruments for laboratory analysis and clinical diagnosis of human diseases, namely, medical diagnostic apparatus for testing DNA and RNA samples and medical diagnostic testing instruments for processing and analysis of genetic samples using gene expression tests, gene expression profiling assays and protein biomarkers; medical testing apparatus, equipment and instruments for testing body fluids, blood and plasma, cancer cells, and foetal cells; parts and fittings for the aforesaid goods, namely, diagnostic apparatus, equipment and instruments for cytology, histology and for use in detecting cancer | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Angle Europe Limited
- Other trademarks owned by Angle Europe Limited
- Other trademarks owned by Angle Europe Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named LANDSCAPE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 7, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 29, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 28, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 7, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 7, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 25, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 25, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 25, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 9, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 9, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 8, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 20, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 20, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 20, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 4, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 29, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 29, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 29, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 29, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 31, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 30, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 30, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Nov 12, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Oct 25, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 25, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 4, 2023 | GNS1 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | — |
| Aug 4, 2023 | GNSF | SUBSEQUENT FINAL EMAILED | — |
| Aug 4, 2023 | CFRC | SUBSEQUENT FINAL REFUSAL WRITTEN | — |
| Aug 1, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 1, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 1, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 3, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 9, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 8, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 8, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 27, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 27, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 27, 2023 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Apr 27, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 27, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 27, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 15, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 26, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 26, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 5, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 4, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 26, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| May 24, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 20, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 19, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |